Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy

Geraint B Rogers1, Lucas R Hoffman, Marvin Whiteley

  • 1King's College London, Molecular Microbiology Research Laboratory, Pharmaceutical Science Division, 150 Stamford Street, Franklin-Wilkins Building, King's College London, London, SE1 9NH, UK.

Insights

New analytical methods for polymicrobial infections can predict clinical outcomes and assess antimicrobial therapy effectiveness in cystic fibrosis (CF) patients. This framework aids in interpreting complex data for improved CF respiratory disease management.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Culture-independent analyses are generating vast data on polymicrobial infections.
  • Interpreting this data requires a robust framework to benefit patient care.
  • Cystic fibrosis (CF) lower airway infections serve as a model to develop such a framework.

Purpose of the Study:

  • To establish a framework for interpreting data from polymicrobial infections.
  • To identify microbial community markers predicting infection dynamics and clinical outcomes in CF.
  • To assess the direct characterization of antimicrobial therapy impact for treatment optimization in CF.

Main Methods:

  • Utilizing a model system of cystic fibrosis lower airway infections.
  • Applying new conceptual and technological advances in culture-independent analyses.
  • Examining strategies to identify predictive microbial markers and assess therapeutic impact.

Main Results:

  • Emerging analytical strategies are poised to increase data on polymicrobial infections.
  • A framework is needed to translate this data into clinical decision-making.
  • The study explores the potential of these strategies in CF respiratory disease.

Conclusions:

  • New analytical strategies offer opportunities to better understand and manage polymicrobial infections.
  • Developing interpretive frameworks is crucial for leveraging big data in clinical settings.
  • This approach can lead to improved patient outcomes, particularly in complex diseases like CF.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...